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7.1  Introduction 
Between 1980 and 1995, the number of individuals covered by managed 
care plans grew more than fivefold. With this increase have come growing 
concerns about the quality of the care provided by  managed care plans. 
There have been a number of responses to these concerns: the establish- 
ment of the National Committee on Quality Assurance (NCQA) to mea- 
sure health care quality and provide accreditation of health plans; the at- 
tempt by  some health care plans to create legally enforceable national 
standards for patient protection; and the formation of a presidential advi- 
sory committee on health care quality. 
Despite the widespread interest in measuring health care quality, there 
is still limited understanding of the differences in the quality of managed 
care and more traditional fee-for-service (FFS) health plans. Indeed, in 
their survey of research on the topic, Miller and Luft (1997) concluded 
that it is difficult to draw definitive conclusions about the differences be- 
tween the two types of coverage. Of the 15 studies they reviewed, some 
found evidence that managed care plans offer higher quality care than 
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FFS plans; others found just the opposite; and still others found little 
difference between the two types of health plans. 
Research on quality takes two approaches. In one approach, researchers 
examine the process of health care, comparing the ways in which health 
care providers treat disease. In the second approach, researchers compare 
patients’ health outcomes. 
For example, Sheldon Retchin and coauthors (Retchin and Brown 1990, 
1991; Retchin and Preston 1991; Retchin et al. 1992), taking the process 
approach to study the medical management of colorectal cancer, diabetes, 
and congestive heart failure, found no meaningful differences in the way 
patients in managed care plans are treated compared to patients in fee- 
for-service plans. In a more recent study, however, Retchin et al. (1997) 
found that stroke patients covered by managed care plans were less likely 
to be discharged to a rehabilitation center, suggesting that they received 
less comprehensive (and perhaps lower quality) therapy. 
An example of the outcomes approach is Retchin et al. (1992), which 
found no differences in the health status of elderly patients under the two 
types of coverage. Similarly,  Yelin, Criswell, and Feigenbaum (1996) found 
no outcome difference for patients suffering from rheumatoid arthritis. By 
contrast, Ware et al. (1996) did find differences between managed care 
and FFS plans. They found that, over a four-year period, chronically ill 
nonelderly patients fared better in managed care plans, while chronically 
ill elderly and poor patients fared better in the FFS plans. Exactly why 
they observed different patterns depending on age and income remains an 
open question. 
There are a number of studies that combine the process and outcomes 
approaches to measure quality. Young and Cohen (1991) found that man- 
aged care patients were less likely to receive coronary artery bypass graft 
and arteriography following AMI, but there were no statistically signifi- 
cant differences in post-AM1 mortality. Similarly, Cutler, McClellan, and 
Newhouse (1997) found lower resource utilization in managed care plans 
but no difference in AM1 mortality rates. Carlisle et al. (1992) took a simi- 
lar approach, although with a more in-depth analysis of  the process of 
medical care for AM1 patients. They found higher-quality processes and 
lower AM1 mortality rates in managed care plans2 
In this paper, we  take a different approach. In particular, we  compare 
1. The NCQA takes the process approach, collecting information, for example, on whether 
health plans screen for breast  and cervical cancer, advise smokers to quit smoking, and 
prescribe appropriate medication for heart disease. 
2. One limitation of this study, however, is that it covers only three HMOs. The three are 
among the most successful HMOs in the United  States, whereas the patients in the FFS 
plans were drawn from a broader sample reflecting hospitals and health care providers of 
average quality. It is an open question whether one would continue to see differences in 
performance if one compared the FFS patients to patients  in a broader cross-section of 
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the hospitals and physicians that treat managed care patients and FFS 
patients. The starting point for our analysis is the large literature establish- 
ing that patients have better clinical outcomes when they are treated by 
physicians and hospitals with more experience treating the disease. For 
example, it has been shown that the patients of  surgeons and hospitals 
that perform a larger number of coronary artery bypass grafts (CABGs) 
are less likely to die during or shortly after the procedure. The relationship 
between physician and hospital volume and outcomes has also been estab- 
lished for a wide range of  surgical procedures and some medical treat- 
ments of chronic illness, including orthopedic surgery, angioplasty, organ 
transplantation, colorectal and breast cancer, hysterectomy, and AIDS. 
The precise mechanism that links volume and outcome is unknown. It 
could be that experience makes physicians and hospitals better; that is, 
there is some sort of learning-by-d~ing.~  Or it could be that higher-volume 
hospitals and physicians attract more patients because they are correctly 
perceived by patients to be better. For our purposes, the exact cause of the 
relationship between volume and outcome is less important than the fact 
that such a relationship exists. 
Thus, our empirical goal is simply to examine whether patients in man- 
aged care plans tend to be treated by higher- or lower-volume physicians 
and hospitals. We  analyze this question using data on all hospital dis- 
charges in Massachusetts in 1995. These data identify the physicians and 
hospitals providing the care, as well  as the patient’s insurance plan (e.g., 
Harvard Community Health Plan, HMO Blue, Blue Cross/Blue Shield, 
Medicare, etc.). The data set also provides fairly detailed clinical informa- 
tion-patient  diagnoses  and  procedures  performed-as  well  as  some 
demographic information on the patients. 
We examine the relationship between managed care and volume for sur- 
geries related to three types of  cancer: breast cancer, colorectal cancer, 
and gynecologic cancer. We  chose these particular diseases because they 
are almost always treated surgically, and thus there are unlikely to be ma- 
jor  differences in whether managed  care patients  or FFS patients  are 
treated surgically. We find that, on average, and after controlling for demo- 
graphic differences, patients with breast cancer who are covered by man- 
aged care plans are operated on by physicians who performed 22 percent 
fewer procedures  than  the  physicians  of  FFS patients. Managed  care 
patients  with  gynecologic cancers are operated  on by  physicians who 
perform  25 percent  fewer surgeries. There is  no appreciable difference 
between managed care and  FFS plans in  the volume of  the physicians 
operating on patients with colorectal cancer. 
3. Laffel et al. (1992) suggests that learning by  doing is part of the explanation. They 
examined the performance of physicians and hospitals as they became more experienced 
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These averages mask  considerable heterogeneity across plans.  Some 
managed care plans use physicians with volumes that are considerably 
lower than the average. For example, one of the plans used physicians 
performing 43 percent fewer breast surgeries and 68 percent fewer hyster- 
ectomies. By contrast, patients in another plan were treated by physicians 
who were  slightly less experienced than the physicians of FFS patients, 
and the difference was statistically insignificant. 
We also find that managed care patients tend to be treated at hospitals 
that perform fewer procedures. For example, in the case of breast cancer 
surgery, patients in five of the six largest plans are treated at hospitals with 
significantly lower volumes-hospitals  with volume 35 percent below the 
average of FFS patients’ hospitals. One finds similar results for colorectal 
cancer surgery, and statistically insignificant differences for gynecologic 
cancer surgery. However, one of the managed care plans sends patients to 
hospitals with 2341 percent higher volume than the hospitals of  FFS 
patients (depending on the procedure). 
If  one accepts the view that volume and quality are related, then these 
results indicate that, in many cases, managed care plans offer lower qual- 
ity care than FFS plans. The results also indicate that not all managed 
care plans are alike; not surprisingly, some are better than others. More- 
over, even the same managed care plans can offer different quality care for 
different diseases. 
These results are consistent with Escarce, Shea, and Chen (1997), who 
find that managed care patients undergoing coronary artery bypass graft 
in southeastern Florida were more likely than FFS patients to be treated 
at lower-volume hospitals. By contrast, Chernew, Scanlon, and Hayward 
(1998) find that in 1991 in California, managed care patients were more 
likely to be treated at high-quality hospitals-those  with low mortality 
rates (and probably high volume). The differences in the results across 
studies is consistent with our view that not all managed care plans are 
alike, and it also suggests that health care markets may differ. More re- 
search into understanding these differences would clearly be useful. 
In the next section of the paper, we  discuss the data used in this study 
and describe our empirical approach. Section 7.3 presents the basic empir- 
ical results. We discuss the implications of the results and suggest future 
research opportunities in section 7.4. 
7.2  Data and Empirical Approach 
We  use the 1995 hospital case mix and charge data compiled by  the 
Division of Health Care Finance and Policy of the Massachusetts Office 
of Health and Human Services. Like most states, Massachusetts requires 
hospitals to report detailed clinical and financial information on all hospi- 
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(encrypted) physician identifiers in the data set and identifies the health 
care plan by name and type.4  We use 1995 data because it is the first full 
year with physician identifiers, and the 1996 data were not available when 
we  began this study. 
While, in principle, one could analyze all hospital admissions, we chose 
not to do so. The reason is that hospital admissions and surgeries may 
differ in the extent to which they are discretionary. For example, prostate 
cancer can be treated with surgery or by outpatient radiation therapy. Be- 
cause we  did not want our analysis to be confounded by  the possibility 
that managed care plans and fee-for-service plans differ in the extent to 
which they treat patients on an inpatient or outpatient basis, we chose to 
focus on diagnoses and treatments where there is little discretion as to 
whether to perform inpatient surgery. While there are possibly many such 
diagnoses and treatments, we  focus on the following three: (1)  breast 
cancer treated with mastectomy or l~mpectomy;~  (2) gynecologic cancer 
(ovarian, uterine, cervical) treated with hysterectomy (total abdominal or 
radical);6 and  (3) colorectal cancer treated with  resection of  colon or 
rectum.’ 
For each of these procedures there is evidence that the patients of high- 
volume providers have better outcomes. As a measure of experience with 
one of the procedures, for each physician we calculate the total number of 
such procedures the physician performed during the year. This number 
includes procedures that were performed for diagnoses other than cancer, 
such as hysterectomy for nonmalignant uterine fibroids.*  Of course, this 
measure-which  we  refer to as physician volume-is  only an imperfect 
proxy for the physician’s experience with the procedure, and an even more 
imperfect proxy for the physician’s skill with the procedure. Unfortunately, 
we  were  unable to get  further information on physicians such as years 
of practice, board certification, and subspecialty training. The analogous 
measure of a hospital’s experience with one of the procedures is the total 
number of the procedures performed at the hospital for the relevant diag- 
noses, which we refer to as hospital volume. 
Our focus is on the relationship between the patient’s health plan and 
4. Other states may indicate the type of health care coverage but not the actual name of 
the health plan. 
5. Breast cancer is defined here as ICD9 hospital codes 1740-1749  inclusive. The surgical 
procedures are ICD9 hospital codes 8521-8523  inclusive, 8541, and 8543. 
6. Gynecologic cancer is defined here as ICD9 hospital codes 179 and 1800-1 839 inclusive; 
total abdominal hysterectomy is ICD9 code 6840, and radical abdominal hysterectomy is 
ICD9 code 6860. 
7. Colorectal cancer is defined here as ICD9 hospital diagnoses codes 1530-1 541 inclusive; 
the procedures are ICD9 hospital procedure codes 4573-4576  inclusive and 4863. 
8. An alternative measure of physician experience with the procedure could include only 
the procedures performed  to treat the cancer diagnoses. Although we  do not  report the 
results, the basic conclusions are unaffected by  this alternative definition of physician expe- 
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the experience of  the physicians treating the patient. There are several 
different categories of health  plans recorded in the Massachusetts case 
mix data. Two are Medicaid and Free Care (a state-run program for the 
otherwise uninsured), which we exclude from the analysis because the indi- 
gent populations they serve are likely to be quite different from the popula- 
tion with private insurance and Medicare. There are four managed care 
plan  categories: health  maintenance  organizations  (HMOs),  preferred 
provider organizations (PPOs), commercial managed care, and Medicare 
managed care. Because the differences among HMOs, PPOs, and commer- 
cial managed care are unclear-at  least in the way they are coded in the 
data-we  make no distinction among these types of plans. 
In 1995, the managed care plans in Massachusetts with the largest num- 
ber  of  hospital admissions were  (1) HMO Blue (a managed care plan 
offered by  Blue Cross/Blue Shield), with 35,949 admissions; (2) Harvard 
Community Health Plan (HCHP), with 30,621 admissions; (3) Tufts Asso- 
ciated Health Plan, with 24,584 admissions; (4) Pilgrim Health Care (since 
merged with HCHP), with 20,379 admissions; (5) Fallon, with 11,488 ad- 
missions; and (6) Bay State Health Care (another Blue CrosdBlue Shield 
managed care plan), with 9,997 admissions. In our analysis, we will break 
out the results for these large managed care plans, and group all other 
managed care plans together. Because of the possibly sensitive nature of 
our results, we will not identify these plans by name when we  present the 
specific results. 
There are also a number of different types of fee-for-service plans. The 
largest is Medicare, with 287,285 hospital admissions, and the largest pri- 
vate plan is  Blue Cross/Blue Shield Indemnity, with 40,269 admissions. 
There are also 31  commercial plans identified by  name, the  largest of 
which is John Hancock Life Insurance, with 4,211 hospital admissions. In 
our analysis we  separate out the results for Medicare fee-for-service, and 
we group Blue Cross/Blue Shield together with all commercial FFS plans. 
In addition to the type of health insurance, there are other factors that 
can have an effect on physician and hospital choice. In particular, proxim- 
ity to high-volume hospitals should increase the likelihood that patients 
are treated by  high-volume providers. As a measure of proximity, we  use 
the shortest distance from the zip code of the patient’s residence to the 10 
highest-volume hospitals for the proced~re.~  Income may also have an 
effect on provider choice since higher-income patients are likely to be more 
educated health care consumers. Although we do not have patient income 
data, we  do have information on median income in the patient’s zip code 
of residence. Age and race may also affect provider choice. 
In the patient-level regression analysis for each procedure, we examine 
9. One could also calculate distance to high-volume physicians, but it is highly correlated 
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whether managed care patients are treated by  higher- or lower-volume 
providers than are FFS patients, controlling for patient demographic  char- 
acteristics. Thus, the regressions take the following form: 
Provider Volume,  =  a0  +  C,cx,Insurance Planll +  P,ln (Agec) 
+ p,ln (Income,) + CkP3kRace  Dummies, + P,ln  (Distance,) +  E,, 
where Provider Volume refers to the number of procedures performed by 
the provider (hospital or physician) during the year, and i indexes patients. 
Before presenting the results of  the regression analysis, it is worth re- 
viewing the characteristics of the sample. Table 7.1 provides summary sta- 
tistics for each of the three cancer surgeries. The mean physician volumes 
Table 7.1  Sample Summary Statistics 
Variable 
Breast Cancer  Colorectal Cancer  Gynecologic Cancer 
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Note: The table records means of some of the variables in the data set broken out by breast 
cancer surgery, colorectal cancer surgery, and gynecologic cancer surgery. (See notes 5-7  for 
more precise definitions of the diseases and surgeries.) The number in brackets is the median 
of the variable, and the number in parentheses is the standard deviation. Physician volume 
is the number of  procedures performed  by  the physicians, including those that were not 
performed for a cancer diagnosis. The sample includes only those patients covered by private 
insurance and Medicare, thus eliminating patients covered by  Medicaid, Free Care, other 
government programs, and patients paying themselves. 236  Sarah Feldman and David Scharfstein 
for breast cancer surgery, colorectal cancer surgery, and gynecologic can- 
cer surgery are 15.6, 18.4, and 21.0, respectively. There is substantial het- 
erogeniety in  the physician volumes for each of  these procedures.  For 
example, the standard deviation  of physician volume for breast  cancer 
surgery is  14.5, almost as large as the mean. The physician in the lowest 
25th percentile performs 6 surgeries, while the physician in the 75th per- 
centile performs 20. 
These numbers count physicians each time they perform surgery, thus 
oversampling the high-volume physicians and understating the number 
of low-volume physicians. For example, of the 400 physicians performing 
at least  1 breast  cancer surgery in the sample, 25 percent performed 3 
or fewer, 75 percent performed 9 or fewer, and only 7.5 percent (30 physi- 
cians) performed 20 or more. For gynecologic cancer, the median physi- 
cian performed only 1 hysterectomy, and there were only  14 out of 313 
(4.5 percent) who performed 20 or more. For colon cancer, 451 physicians 
performed at least 1 surgery for the disease, the median performed 9 sur- 
geries, and 58 (12.9 1 percent) performed 20 or more surgeries. 
Table 7.1 shows that mean hospital volume is  91.9 for breast  cancer 
surgery, 119.2 for colon cancer surgery, and 65.1 for gynecologic cancer 
surgery. Here, too, the variation across providers is very large. Of the 76 
hospitals performing at least 1 surgery for breast cancer, 25 percent per- 
formed fewer than 15,75  percent performed fewer than 52, and there were 
only 6 that performed more than  100 surgeries during the year. The vol- 
ume numbers are even lower for gynecologic cancer: Of the 66 hospitals 
operating on women with gynecologic cancer, 25 percent performed fewer 
than 4 such procedures, 75 percent performed fewer than 17, 7 performed 
more than 60 procedures, and only 3 performed more than  100. In the 
case of colorectal cancer, the hospital volume numbers are considerable 
higher. Of the 73 hospitals, 25 percent performed fewer than 29, 50 per- 
cent performed fewer than 65, and 75 percent performed fewer than 100. 
There are 19 hospitals  that performed  100 or more surgeries for colon 
cancer. 
In addition to summary statistics on some of the demographic variables, 
table 7.1 provides information on patients’ insurance. Given that cancer 
tends to be concentrated among the elderly, it is not surprising that most 
of the patients (51-78  percent depending on the cancer) have Medicare 
insurance. However, only a small fraction of these Medicare patients (3-4 
percent) are covered by managed care. The non-Medicare patients are cov- 
ered by private managed care plans or fee-for-service  plans. Depending on 
the procedure, between 60 percent and 65 percent of these privately in- 
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7.3  Empirical Results 
7.3.1  Physician Volume 
For each of the three surgeries, table 7.2 lists the mean physician vol- 
umes for (1) all private fee-for-service plans; (2) the six largest private 
(non-Medicare, non-Medicaid) managed care plans; (3) all other private 
managed  care plans  grouped  together;  (4)  standard  Medicare fee-for- 
service; and (5) Medicare managed care plans grouped together. 
In all three cases, the mean physician volume of private FFS patients 
exceeds that of private managed care patients. We  discuss the results for 
each of the three surgeries in turn. 
Table 7.2  Mean Physician Volume for Various Health Care Plans 
Type of Health  Breast Cancer  Colorectal Cancer  Gynecologic Cancer 
Insurance Plan  Surgery  Surgery  Surgery 
Private fee-for-service 
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Note: The table records the mean physician volumes broken out by breast cancer surgery, 
colorectal cancer surgery, and gynecologic cancer surgery and type of health plan. (See notes 
5-7  for more precise definitions of the diseases and surgeries.) The number in parentheses is 
the p-value of the difference with the private fee-for-service health plans, calculated using 
White’s (1980) robust standard errors. Physician volume is the number of procedures per- 
formed by the physicians, including those that were not performed  for a cancer diagnosis. 
The sample includes only those patients covered by  private insurance and Medicare, thus 
eliminating patients covered by Medicaid, Free Care, other government programs, and pa- 
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Breast Cancer Surgery 
The mean physician volume for private FFS plans is 20.8, compared to 
16.4 for private managed care patients; that is, FFS is 27 percent higher 
than managed care. For all of the large managed care plans except Plan 
A, the differential is statistically significant. In the case of Plan B and Plan 
F,  the difference in physician volume is very  large; physicians that treat 
private FFS patients perform 60 percent more surgeries than the physi- 
cians treating Plan B and Plan F patients (i.e., 20.5 versus 13.0 for Plans 
B and F). 
Physicians treating patients covered by Medicare-both  FFS and man- 
aged care-perform  fewer surgeries than the physicians treating private 
FFS patients. The differences are large: The physician  volume of  pri- 
vate FFS patients  is  49  percent  higher  than  the  physician  volume  of 
Medicare FFS patients (14.0) and 40 percent higher than the physician 
volume of Medicare managed care patients (14.9). 
Table 7.3 indicates the  predicted physician volumes for  the  various 
health care plans using the regression model described in section 7.2. The 
predicted values are based on the means of the demographic variables- 
age, income, distance to large hospitals, and race. The table indicates that 
there continue to be statistically significant differences in physician vol- 
umes between private managed care and FFS plans and that the magni- 
tude of the differences is not changed much. The difference between Medi- 
care and private FFS is reduced and is no longer statistically significant. 
Colorectal Cancer Surgery 
The mean volume of physicians treating private FFS patients with colo- 
rectal cancer is  18.0 as compared to  17.3 for private managed care pa- 
tients. The overall difference is not statistically significant and only one 
of  the seven private managed care plans, Plan A, exhibits a statistically 
significant  difference in  physician  volume  as compared  to FFS plans. 
The regression analysis that controls for demographic variables does not 
change this conclusion. The mean physician volume of Medicare FFS pa- 
tients is slightly higher (but insignificantly so) than FFS patients, while the 
mean physician volume of Medicare managed care patients is significantly 
higher than that of private FFS patients. In table 7.3, once demographic 
controls are included, the difference between Medicare FFS and private 
FFS becomes statistically significant and the difference between Medicare 
managed care and private FFS remains statistically significant. 
Gynecologic Cancer Surgery 
The average number of procedures performed by  physicians treating 
private FFS patients for gynecologic cancer is 23.9 as compared to 18.3 
for physicians treating patients in private managed care plans. Physicians Managed Care and Provider Volume  239 
Table 7.3  Mean Demographically Adjusted Physician Volume for Various Health 
Care Plans 
Type of Health  Breast Cancer  Colorectal Cancer  Gynecologic Cancer 
Insurance Plan  Surgery  Surgery  Surgery 
Private fee-for-service 
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Note: The table records the predicted physician volumes broken out by breast cancer surgery, 
colorectal cancer surgery, and gynecologic  cancer surgery and type of health plan. (See notes 
5-7  for more precise definitions of the diseases and surgeries.) The number in parentheses is 
the p-value of the difference with the private fee-for-service health plans, calculated using 
White’s (1980) robust standard errors. Physician volume is the number of procedures per- 
formed by the physicians, including those that were not performed for a cancer diagnosis. 
The sample includes only those patients covered by  private insurance and Medicare, thus 
eliminating patients covered by Medicaid, Free Care, other government programs, and pa- 
tients paying themselves. The demographic adjustments include race, log of age, log of  me- 
dian income in the patient’s zip code, and the log distance to the closest of the 10 highest 
volume hospitals performing the procedure. The predicted physician volumes are derived 
from the regression model described in the text evaluated at the means of the demographic 
controls. 
used by patients in four of the six largest managed care plans have statisti- 
cally significant lower volume than physicians used by FFS patients. The 
magnitude of  the differences are very large. In the case of Plan  F,  the 
average physician volume is 62 percent lower than the average volume of 
private FFS plans (9.2 versus 23.9). Physician volume in Medicare man- 
aged care plans (8.4 surgeries per year) is also significantly lower than 
physician volume in private FFS plans and Medicare FFS plans (22.0 sur- 
geries per year). The differences continue to hold once demographic con- 
trols are included, as table 7.3 shows. 240  Sarah Feldman and David Scharfstein 
7.3.2  Hospital Volume 
Tables 7.4 and 7.5  indicate that managed care and FFS patients are 
treated at hospitals with significant differences in the number of  proce- 
dures they perform. Table 7.4 gives the raw means for the various plans, 
while table 7.5 adjusts the means for demographic factors. 
Breast Cancer Surgery 
The average private FFS patient is treated at a hospital that performs 
120.9 surgeries per year, while the average managed care patient is treated 
at a hospital that performs 99.8 surgeries per year. However, patients in 
one of the managed care plans, Plan A, are treated by hospitals with sig- 
nificantly higher volume than the patients covered by private FFS plans- 
Table 7.4  Mean Hospital Volume for Various Health Care Plans 
Type of Health 
Insurance Plan 
Breast Cancer  Colorectal Cancer  Gynecologic Cancer 
Surgery  Surgery  Surgery 
Private fee-for-service 











































































Note: The table records the mean hospital volumes broken out by  breast cancer surgery, 
colorectal cancer surgery, and gynecologic cancer surgery. (See notes 5-7  for more precise 
definitions of the diseases and surgeries.) The number in parentheses is the p-value of the 
difference with the private fee-for-service health plans, calculated using White’s (1980) robust 
standard errors. Physician volume is the number of procedures performed by the physicians, 
including those that were not performed  for a cancer diagnosis. The sample includes only 
those patients covered by private insurance and Medicare, thus eliminating patients covered 
by Medicaid, Free Care, other government programs, and patients paying themselves. Managed Care and Provider Volume  241 
Table 7.5  Mean Demographically Adjusted Hospital Volume for Various Health 
Care Plans 
Type of Health  Breast Cancer 
Insurance Plan  Surgery 
Colorectal Cancer  Gynecologic Cancer 
Surgery  Surgery 
Private fee-for-service 
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Note: The table records the predicted hospital volumes broken out by breast cancer surgery, 
colorectal cancer surgery, and gynecologic cancer surgery and type of health plan. (See notes 
5-7  for more precise definitions of the diseases and surgeries.) The number in parentheses is 
the p-value of the difference with the private fee-for-service health plans, calculated using 
White’s (1980) robust standard errors. Physician volume is the number of procedures per- 
formed by  the physicians, including those that were not performed for a cancer diagnosis. 
The sample includes only those patients covered by  private insurance and Medicare, thus 
eliminating patients covered by  Medicaid, Free Care, other government programs, and pa- 
tients paying themselves. The demographic adjustments include race, log of age, log of me- 
dian income in the patient’s zip code, and the log distance to the closest of the 10 highest 
volume hospitals performing the procedure. The predicted hospital volumes are derived from 
the regression model described in the text evaluated at the means of the demographic con- 
trols. 
171.1 for Plan A versus 120.9 for the private FFS plans. As will  be  dis- 
cussed shortly, this differential for Plan A is true of the other procedures 
as well. Interestingly though, while Plan A patients are treated at higher- 
volume hospitals than private FFS patients, table 7.2 indicates that they 
are not treated by  higher-volume physicians. In fact, patients covered by 
Plan A are treated by relatively low-volume physicians at high-volume hos- 
pitals. 
The patients covered by  the other managed care plans are treated at 
significantly lower-volume hospitals-from  23 percent lower in the case 242  Sarah Feldman and David Scharfstein 
of Plan C to as much as 56 percent lower in the case of Plan F. On average, 
patients in  Plans B through F are treated at hospitals with volumes of 
79.2, 34 percent below the average for FFS patients. 
Finally, patients covered by  both types of Medicare plans-FFS  and 
managed care-are  treated at lower-volume hospitals. 
Table 7.5 presents the means once they are adjusted for demographic 
differences, and there is no appreciable difference in the results. Plan A 
patients are treated at higher-volume hospitals than FFS patients, and pa- 
tients in Plans B through F are treated at hospitals with 35 percent lower 
volume. 
Colon Cancer Surgery 
The same pattern exists for colon cancer surgery, although the magni- 
tude of the differences are somewhat smaller. On average, patients in pri- 
vate FFS plans are treated at hospitals with a volume of 134.7 colorectal 
surgeries, while the corresponding volume is  121.2 for private managed 
care plans. Here, too, Plan A patients are treated at higher-volume hospi- 
tals than FFS patients. As table 7.2 shows, they are treated by low-volume 
physicians at these high-volume hospitals. Patients in all other managed 
care plans are treated at lower-volume hospitals than patients in private 
FFS plans. On average, they are treated at hospitals with a volume of 
1  10.2 as compared to 134.7 for FFS patients, an 18 percent differential. 
The same pattern of results carry over to table 7.5, where demographic 
controls are included. Plan A patients are treated at higher-volume hospi- 
tals and patients in Plans B through F are treated at hospitals that perform 
an average of 22  percent fewer surgeries than the hospitals  of FFS pa- 
tients. 
Gynecologic Cancer Surgery 
The difference between private FFS and private managed  care plans 
are somewhat less pronounced for gynecologic cancer surgery. The overall 
mean for private FFS patients is 67.1, while it is 63.4 for private managed 
care patients. Plan A patients are treated at hospitals with relatively high 
volumes, those with an average volume of 90.8. Patients in the other plans 
are treated at hospitals with lower volume, but the only plan where the 
difference is statistically significant is Plan B,  with an average volume of 
33.0 as compared to 67.1 for private FFS patients. Inclusion of demo- 
graphic controls does not alter this basic conclusion. 
7.3.3  Effect of Demographic Variables 
Panels A and B of table 7.6 provide information on the effect of demo- 
graphic variables on the choice of physician and hospital. The effects are 
estimated from the regression analysis described in section 7.2 and are 
evaluated at the means of all the other variables in the regression. Table 7.6  Effects of Demographic Variables on Physician Volume and 
Hospital Volume 
Breast Cancer  Colorectal Cancer  Gynecologic Cancer 
Demographic Variable  Surgery  Surgery  Surgery 
A. Physician  Volume 
Income 
1 st. dev. below mean  13.8  16.1 
I  st. dev. above mean  16.9  17.9 
(< 0.001)  (<  0.001) 
Age 
1 st. dev. below mean  17.8  17.9 
1 st. dev. above mean  12.9  16.1 
(< 0.001)  (0.005) 
Race 
African American  14.2  14.8 
White  15.5  18.3 
(0.557)  (0.007) 
Distance to high-volume hospital 
1 st. dev. below mean  15.4  18.2 
1 st. dev. above mean  15.3  15.8 
N  2,042  2,220 
(0.824)  (0.001) 
B. Hospital  Volume 
Income 
1 st. dev. below mean  80.5  110.0 
1 st. dev. above mean  103.3  128.4 
(<  0.001)  (< 0.001) 
Age 
1 st. dev. below mean  102.5  127.4 
1 st. dev. above mean  81.3  111.0 
(< 0.001)  (<  0.001) 
Race 
African American  148.6  131.9 
White  88.3  129.2 
(0.002)  (0.795) 
Distance to high-volume hospital 
1 st. dev. below mean  98.0  137.3 
1 st. dev. above mean  85.8  101.1 
N  2,042  2,220 
(< 0.001)  (< 0,001) 
17.0 
25.0 
























Note; The table records the predicted physician volumes (panel A) and hospital volumes 
(panel B) broken out by  breast cancer surgery, colorectal cancer surgery, and gynecologic 
cancer surgery for different values of the demographic control variables. (See notes 5-7  for 
more precise definitions of the diseases and surgeries.) The number in parentheses is the p- 
value of the coefficient of the demographic control in the regression analysis described in the 
text.  Physician volume is the number of procedures performed by the physicians, including 
those that were not performed for a cancer diagnosis. The sample includes only those pa- 
tients covered by private insurance and Medicare, thus eliminating patients covered by  Med- 
icaid, Free Care, other government programs, and patients paying themselves. The demo- 
graphic controls are race, log of age, log of median income in the patient’s zip code, and the 
log distance to the closest of the 10 highest volume hospitals performing the procedure. 244  Sarah Feldman and David Scharfstein 
The tables indicate that higher-income patients-or  more precisely, pa- 
tients living in higher-income zip codes-are  more prone to go to higher- 
volume physicians (panel A) and higher-volume hospitals (panel B). For 
all the procedures, the effect of income on volume is highly statistically 
significant. In the case of breast cancer surgery, patients with income one 
standard deviation above the mean are treated by physicians with 22 per- 
cent higher volume than the physicians of patients with income one stan- 
dard deviation below the mean (16.9 procedures versus 13.8). The higher- 
income breast  cancer patients  are treated  at hospitals with 28  percent 
higher volume than the hospitals that treat lower income patients (103.3 
versus 80.5). 
The effects of income on physician and hospital volume are somewhat 
smaller for colorectal cancer surgery; higher-income patients are treated 
by  physicians that perform  11 percent more surgeries and than the phy- 
sicians of lower-income patients (17.9 versus 16.1) and at hospitals that 
perform 17 percent more surgeries (128.4 versus 1 1O.0).l0  Finally, the effect 
of income on physician volume is quite large in  the case of gynecologic 
cancer surgery, with higher-income patients being treated by  physicians 
that  perform  47  percent  more  surgeries than  the  physicians  of  lower- 
income patients (25.0 versus 17.0). The effect of income on hospital vol- 
ume for this procedure is  smaller; higher-income patients are treated at 
hospitals with only 11 percent higher volume than the hospitals of lower- 
income patients (69.5 versus 60.7). 
These results are consistent with the findings of McClellan and Skinner 
(1997) that higher-income Medicare patients use more Medicare services, 
mostly physician and outpatient services. This suggests that higher-income 
patients are more aggressive in seeking high-quality health care. Thus, it 
is not surprising that they tend to seek care from higher-volume physicians 
and hospitals. 
Age also has an effect on provider choice; older patients tend to be 
treated by  lower-volume physicians and hospitals. For example, the av- 
erage 84-year-old with breast cancer (one standard deviation above the 
mean) is treated by physicians who performed 12.9 breast cancer surgeries 
during the year, while  the average 61-year-old with breast  cancer (one 
standard deviation below the mean) was treated by a physician who per- 
formed 17.8 (38 percent more) breast cancer surgeries. The average 84- 
year-old is treated at hospitals that perform 8 1.3 breast cancer surgeries, 
while  the average 61-year-old is  treated at hospitals that perform  102.5 
surgeries. There are similar effects of age for the other procedures, though 
the magnitudes of the effects are smaller. It is not completely clear how to 
10. A small part of the difference in the effect of income for colorectal and breast cancer 
surgeries is attributable to the lower standard deviation of income for colorectal cancer pa- 
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interpret the results on age. One possible interpretation is that it is more 
difficult for elderly patients to find high-volume physicians or travel to 
high-volume hospitals. 
Table 7.6 presents inconclusive evidence on the effects of race on pro- 
vider choice. White patients tend to be treated by  higher-volume physi- 
cians than African American patients for colorectal cancer, but the oppo- 
site is true for gynecologic cancer, and there is no significant difference for 
breast cancer. African American women are treated for breast cancer at 
hospitals with significantly higher volumes than white women, but there 
are no significant effects of  race for colorectal cancer and gynecologic 
cancer. 
Finally, table 7.6 presents evidence that proximity to high-volume hospi- 
tals increases the likelihood that patients will be treated at higher-volume 
hospitals. The effect is relatively small for breast cancer and gynecologic 
cancer and larger for colorectal cancer. Hospital proximity has no effect 
on physician choice for breast cancer and gynecologic cancer, but it does 
have an effect for colorectal cancer. 
7.4  Discussion and Conclusion 
The results of this paper indicate that patients covered by managed care 
plans tend to be treated by lower-volume physicians and at lower-volume 
hospitals than patients covered by FFS plans. Although this is the overall 
pattern, there is quite a bit of variation across health plans. The patients in 
one plan (Plan B) were treated by physicians who performed many fewer 
surgeries than physicians treating FFS patients, while there was little dif- 
ference in physician volume for another plan (Plan C). One of the health 
plans (Plan A) treated their patients at hospitals with considerably higher 
volume than FFS patients, but Plan B patients were treated at hospitals 
with considerably lower volume. If volume is a valid indicator of quality, 
it suggests that there is substantial variation in health care quality across 
managed care plans. 
Our results, at first glance, seem difficult to reconcile with the literature 
on managed care quality, which find little systematic differences in the 
health  outcomes of  managed care and FFS patients. If our results are 
valid-that  is, if  there are quality differences between the two types of 
coverage as a result of  provider-volume differences-why  don’t we  see 
these differences in the health outcomes of managed care and FFS pa- 
tients? There are two possible answers. One is that the literature investigat- 
ing quality differentials tends to focus on outcomes of  chronic diseases 
that are generally managed through medical, rather than surgical, inter- 
vention. The quality of medical intervention may  be harder to measure 
than the quality of the kinds of surgical interventions we are studying. The 
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and the average managed care plan. As our study indicates, however, look- 
ing at averages may mask considerable heterogeneity across plans. Some 
managed care plans may be  better than FFS plans, while others may be 
worse. Ultimately, to reconcile our results with the literature, it would be 
useful to more directly measure the health outcomes of patients in our 
sample. 
One question that we have not addressed is exactly why it is that managed 
care patients tend to be treated by low-volume providers. One possibility 
is that managed care plans limit patients to using relatively low-volume 
providers. They might not be referred to specialists for their procedures, 
or their access to high-volume specialists may  be restricted. In addition, 
managed care health plans may  not send their patients to high-volume 
tertiary-care teaching hospitals because they only have contracts with low- 
volume  community  hospitals.  This  interpretation  is  plausible  because 
lower-cost community hospitals  and low-volume surgeons are likely to 
offer their services at more attractive rates to managed care health plans. 
To  determine whether this is indeed the explanation, one could collect 
information on the hospitals and providers with whom the managed care 
plans have contracts. 
An alternative interpretation of the findings is that managed care plans 
do not restrict patient choice, but rather that individuals who enroll in 
managed care plans are less-aggressive health care consumers. In this in- 
terpretation, even if they had enrolled in an FFS plan, they would choose 
to be treated by  low-volume providers because they care less about the 
quality of their care. This leaves open the question of why  managed care 
plans  don’t  direct  these  patients  to  high-volume  providers  who  offer 
higher-quality care. We suspect the answer again is that high-volume pro- 
viders are more expensive. 
This discussion raises the related question of why  some managed care 
plans use high-volume providers and others do not. Ultimately, the negoti- 
ated prices between health care providers and insurers will depend on pro- 
vider costs and the bargaining power of the two parties. It is likely that size 
gives providers and insurers bargaining power. Thus, one would expect the 
patients of larger insurance plans-those  with more bargaining power vis- 
a-vis the hospitals-to  be treated  by  higher-volume providers than the 
patients of  smaller insurance plans. This implication is  easy to analyze 
with our data. In addition, one could examine whether mergers between 
health plans-such  as that between Harvard Community Health Plan and 
Pilgrim-affected  the volume of  the providers treating patients in  these 
plans. 
Another way  to address this question is  to analyze data from other 
states where managed care penetration levels differ. For example, in south- 
ern states where there is relatively little managed care penetration, high- 
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priced managed care contracts. As a result, one might expect to see bigger 
differences in the volume of physicians and hospitals treating managed 
care and fee-for-service patients in these states. By contrast, in California, 
the state with the largest managed care penetration,  there may  be little 
difference between managed care and fee-for-service plans, because all 
hospitals and physicians are reliant on managed care business. With  a 
long enough time series, one could also examine how changes over time 
in managed care penetration affect the allocation of patients across low- 
volume and high-volume providers. 
Finally, in order to draw more general conclusions about provider vol- 
ume differences between managed care and FFS, one would have to ana- 
lyze more procedures. Our preliminary analysis of other procedures-in- 
cluding those that are more elective in nature-indicates  that the sort of 
effects we have identified are prevalent, at least in Massachusetts in  1995. 
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